Australia: Regulatory exclusivities for pharmaceuticals

The Australian exclusivity regime for medicines differs from those in place in the northern hemisphere. It also contains subtleties that sponsors (originator and generic/biosimilars) need to know to determine the impact on generic/biosimilar market formation.

First things first: the meaning of data and market exclusivity

The terms “data exclusivity” and “market exclusivity” are often confused or conflated.